Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Last updated: 2018
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2018
- December 20183 results available
- November 20181 results available
- September 20182 results available
- August 20181 results available
- July 20181 results available
- June 20184 results available
- May 20182 results available
- April 20182 results available
- March 20182 results available
- February 20182 results available
- January 20181 results available
Displaying 1 - 15 of 21 items.
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20
Cannabis and Alcohol Use During the Holidays
AlertInformation update | 2018-12-17
Talc - Potential Risk of Lung Effects and Ovarian Cancer
AlertHealth professional risk communication | 2018-12-05
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
AlertHealth professional risk communication | 2018-11-08
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
AlertHealth professional risk communication | 2018-09-18
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles - Update on the Use of Medical Grade Filters
AlertHealth professional risk communication | 2018-09-12
EpiPen (epinephrine USP) Auto-Injector - Interim Order allowing the importation of AUVI-Q in response to shortages of EpiPen and EpiPen Jr
AlertHealth professional risk communication | 2018-08-29
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles
AlertHealth professional risk communication | 2018-07-17
BLINCYTO (blinatumomab) and Benzyl Alcohol Toxicity for Pediatric Patients
AlertHealth professional risk communication | 2018-06-12
TIVICAY, TRIUMEQ and JULUCA (dolutegravir containing medicines) – Possible Risk of Neural Tube Defects
AlertHealth professional risk communication | 2018-06-07
Jamp-Glucose 50 and Jamp-Glucose 75 – Risk of False Negative Oral Glucose Challenge or Tolerance Test Results
AlertHealth professional risk communication | 2018-06-07
New safety information for women using dolutegravir, a medication used to treat HIV infection
AlertInformation update | 2018-06-07
Barbed Sutures and the Potential Risk of Small Bowel Obstruction
AlertHealth professional risk communication | 2018-05-31
Several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing
AlertHealth professional risk communication | 2018-05-01
Percutaneous Radiofrequency Ablation Catheter and the Potential Risk of Atrioesophageal Fistula
AlertHealth professional risk communication | 2018-04-16